Reassessment of Premedication in Surgery

NCT ID: NCT01549691

Last Updated: 2013-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

455 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-03-31

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test the level of anxiety in patients, the day before surgery (late afternoon) and immediately prior to surgery in 3 parallel groups of patients.

* one receiving placebo before going to sleep (before sleep), the day prior surgery and placebo when awakening (awakening), the day of surgery
* one receiving zopiclone (7.5 mg) before sleep and placebo at awakening
* one receiving placebo before sleep and alprazolam (0.5 mg)at awakening

double blind, randomized controlled study

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Eligibility:

* 18 to 65 years old
* elective surgery
* in-hospital preoperative night

Outcome measures:

* anxiety scales
* demographic data

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Premedication Benzodiazepine Anti-anxiety agents Anxiety Surgery Adult Human

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

zopiclone

zopiclone given before sleep, the day before surgery (placebo given at awakening the day of surgery)

Group Type EXPERIMENTAL

Zopiclone

Intervention Type DRUG

7.5 mg before sleep, the evening before surgery

alprazolam

given at awakening, the day of surgery (placebo given before sleep, the day before surgery)

Group Type EXPERIMENTAL

Alprazolam

Intervention Type DRUG

0.5 mg at awakening, the day of surgery

placebo

Placebo given night before operation and the morning of operation

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type DRUG

given night before surgery and at awakening, the day of surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Zopiclone

7.5 mg before sleep, the evening before surgery

Intervention Type DRUG

Alprazolam

0.5 mg at awakening, the day of surgery

Intervention Type DRUG

placebo

given night before surgery and at awakening, the day of surgery

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Imovane Xanax

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18-65 years old
* elective surgery
* in-hospital night before surgery

Exclusion Criteria

* myasthenia gravis
* chronic intake of psychotropic drugs
* opiates intake
* severe obstructive sleep apnea
* intracranial hypertension
* morbid obesity
* myasthenia gravis
* acute severe medical disorder
* non health insurance coverage
* protected patients by law
* pregnancy
* non French speaking
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laurent Beydon, MD

Role: STUDY_CHAIR

University Hospital Angers (Dept of Anesthesia)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Sévigné

Cesson, Brittany Region, France

Site Status

Dept of Anesthesia, Hôpital Maison Blanche

Reims, Champagne, France

Site Status

Centre Paul Papin

Angers, Maine et Loire, France

Site Status

University Hospital

Angers, Maine et Loire, France

Site Status

Clinique St Leonard

Trélazé, Maine et Loire, France

Site Status

Dept of Anesthesia

Le Mans, Maine, France

Site Status

Dept of Anesthesia, Hôpital Tenon

Paris, Île-de-France Region, France

Site Status

Dept of Anesthesia, Hôpital Foch,

Suresnes, Île-de-France Region, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Beydon L, Rouxel A, Camut N, Schinkel N, Malinovsky JM, Aveline C, Marret E, Bildea A, Dupoiron D, Liu N, Daniel V, Darsonval A, Chretien JM, Rault L, Bruna J, Alberti C. Sedative premedication before surgery--A multicentre randomized study versus placebo. Anaesth Crit Care Pain Med. 2015 Jun;34(3):165-71. doi: 10.1016/j.accpm.2015.01.005. Epub 2015 May 23.

Reference Type DERIVED
PMID: 26004882 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-002553-65

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

PHRC 2011-20

Identifier Type: -

Identifier Source: org_study_id